Alveolar macrophages maintain lung homeostasis by performing important roles in immunosurveillance and lung surfactant catabolism. They express high levels of CD44 and are one of the few macrophage populations that constitutively bind hyaluronan, a ligand for CD44 and component of pericellular and extracellular matrices. Using adoptive transfer experiments and a mouse model of inflammation, we found that alveolar macrophages are initially depleted after an inflammatory insult then rapidly self-renew and return to original numbers after the resolution phase. Monocytes recruited to an inflamed lung differentiate and contribute to the alveolar macrophage pool, but this occurs over a much slower time frame than alveolar macrophage self-renewal. CD44 expression on both fetal and bone marrowderived alveolar macrophages promoted their survival and provided a competitive advantage over CD44-deficient alveolar macrophages at homeostasis and after inflammation. CD44-mediated hyaluronan binding was induced by the alveolar environment, and this interaction promoted alveolar macrophage survival both ex vivo and in vivo. Without CD44, alveolar macrophages lacked a hyaluronan coat, were more susceptible to death, and were present at lower numbers in the alveolar space. This demonstrates a new role for CD44 and hyaluronan in promoting alveolar macrophage survival.
INTRODUCTION
The airways are primary entry sites for pathogens and airborne particles 1, 2 where alveolar macrophages (AM^) are a first line of defense to phagocytose pathogens, particulates, and cell debris. [1] [2] [3] Shortly after birth, colony stimulating factor-2 (CSF-2 or granulocyte-macrophage-CSF) drives the differentiation of fetal monocytes into long-lived AM^capable of selfrenewal. [4] [5] [6] [7] Their self-renewal is sufficient to maintain the AM^population at homeostasis and does not require replenishment from bone marrow (BM)-derived monocytes. 3, 6, 7 However, BM-derived cells are capable of developing into AM^, as after AM^ablation by irradiation, subsequent BM reconstitution leads to BM-derived AM^in adult mice. 8 Yolk sac macrophages, fetal liver, and adult monocytes can colonize the lungs of Csf2rb À / À mice and develop into functional AM^, 9 showing that progenitors of different origins can differentiate into AM^, raising the possibility that it is the alveolar environment, not the origin of the progenitor, that determines their differentiation into AM^. 10 In acute inflammation, the numbers of AM^are reduced and then restored after inflammation is resolved. In influenza infection, the recovery of AM^was attributed to AM^self-renewal, 7 whereas 2 months after acute lipopolysaccharide (LPS)-induced inflammation, the majority of AM^were shown to be BM derived. 11 Thus, in adult mice, the extent to which monocytes contribute to AM^renewal after inflammation 10 is not clear, nor are the factors that regulate monocyte differentiation and AM^renewal after inflammation. Such information would considerably aid the understanding of the AM^renewal process that could be crucial for the resolution of inflammation and return to homeostasis.
At homeostasis, AM^are thought to exist in a somewhat immunosuppressive environment where they phagocytose pathogens without alerting other innate immune cells. 3 If they cannot clear the infection, they initiate innate immune responses: for example, in response to Streptococcus pneumoniae 12 and respiratory syncytial virus. 13 However, AM^depletion can also exacerbate pulmonary inflammatory responses, 14, 15 suggesting AM^have an anti-inflammatory role, but the loss of AM^could also lead to greater damage to other cells that further stimulates the immune response. Murine AM^are characterized by the expression of CD11c, Siglec F 3 , as well as their expression of CD44 and the ability to constitutively bind hyaluronan (HA). 16 CD44 is responsible for the binding and uptake of HA in AM^in vitro and during lung development after birth. 17, 18 In bleomycin-induced lung inflammation, CD44
À / À mice have increased HA accumulation, a buildup of apoptotic neutrophils, and the mice die from unremitting inflammation. 19 This phenotype is partially rescued if the mice are reconstituted with CD44 þ / þ BM, 19, 20 implicating a key role for CD44 in HA clearance and resolution of lung inflammation. CD44 also contributes to neutrophil recruitment to inflammatory sites, 21 raising the possibility that CD44 may also contribute to monocyte recruitment to the lungs. Given the constitutive HA binding ability of AM^, we sought to evaluate the significance of CD44 and HA binding in AM^homeostasis and renewal under normal and inflammatory conditions.
RESULTS

CD44
À / À mice have reduced numbers of AM^and CD44 À / À AM^are at a competitive disadvantage under both homeostatic and inflammatory conditions
To determine the significance of constitutive HA binding and CD44 expression by AM^in the alveolar space, we compared bona fide fetal monocyte-derived AM^from CD44
þ / þ and CD44 À / À mice. The number of AM^isolated from the bronchoalveolar lavage (BAL) of CD44 À / À mice was significantly lower compared with CD44 þ / þ mice ( Figure 1a) . A reduction was also observed in AM^isolated from the lung where equivalent numbers of lung cells were isolated from CD44 þ / þ and CD44 À / À mice, ruling out differences in location or total cell numbers in the lungs between the mice (Figure 1b) . No gross differences were observed in the expression of Siglec F, CD11c, or CD11b between the CD44 þ / þ and CD44 À / À AM^ (Figure 1a,b) . This suggested an intrinsic defect in the CD44 À / À AM^, although the alveolar environment can also have a strong influence on AM survival and maturation. [4] [5] [6] 22 To distinguish between these possibilities, AM^were isolated from CD45.2
þ / þ and CD44 À / À mice and instilled into the alveolar space of CD44 þ / þ CD45.1 þ mice in a 1:1 ratio (Figure 1c) . After 24 h, there was still a 1:1 ratio of donor CD44 þ / þ and CD44 À / À AM^in the BAL, demonstrating no advantage of CD44 on the initial engraftment (Figure 1d,g ). However, by day 8 after instillation, there was 42:1 ratio of donor
As the reduced percentage of CD44 À / À AM^was observed in a CD44-sufficient lung environment, this supports an intrinsic defect in these cells. To determine whether instillation of the donor AM^into an inflammatory lung environment would affect the outcome, we instilled LPS 24 h after the instillation of the 1:1 ratio of donor AM^. Analysis of the cells at day 7 after LPS (day 8 after AM^instillation) revealed a similar 2:1 ratio (Figure 1f,h ), indicating no further advantage. It was noted that there were more CD45.2 À CD11c þ host cells at day 7 after LPS treatment compared with untreated ( Figure 1i) . In a different experiment, a comparison of the number of instilled donor GFP þ CD44 þ / þ AM^before and after LPS-induced inflammation showed a threefold increase of AM^on day 7 after LPS relative to days 0 and 1 (Figure 1j) , indicating that AM^had proliferated in response to LPS-induced inflammation. Thus, CD44
À / À AM^have an intrinsic defect that compromised their ability to generate normal numbers of AM^in the alveolar space at homeostasis and decreased their ability to compete with CD44 þ / þ AM^under both homeostatic and inflammatory conditions. CD44 provides an advantage to monocyte-derived AMT o determine whether this CD44 advantage also extends to BM monocyte-derived AM^, we performed a competitive BM reconstitution using CD44
À / À and CD44 þ / þ BM cells into a lethally irradiated CD44-sufficient host. Unlike at homeostasis, this creates an empty niche in the alveolar space, allowing full reconstitution of AM^from BM monocytes. 8 The donor BM cells were distinguishable by CD44 expression and by CD45.1 and CD45.2 allogeneic markers:
BM cells were isolated, mixed in a 1:1 ratio, and 8 million cells were injected intravenously (IV) into lethally irradiated CD45.1 þ mice (Figure 2a) . Seven weeks elapsed to allow for BM reconstitution and then the percentage chimerism was determined in the lung. Monocytes (Ly6C high CD11c À ), neutrophils (Ly6G þ ), and eosinophils (Ly6C low side scatter (SSC) high ) all showed equal chimerism of B1:1 (Figure 2b,c) . However, AM^(CD11c (Figure 2b,c) . Isolation of CD11c þ AM^from the BAL, where they constitute the majority of cells, further demonstrated a 3:1 ratio and a distinct advantage for CD44 (Figure 2b,c) . Although CD44 is expressed on neutrophils, eosinophils, and Ly6C high monocytes, it does not confer a competitive advantage after BM reconstitution in these cells, whereas it does for AM^.
LPS-induced lung inflammation causes a transient loss of AM^and differentiated monocytes gain HA binding
We next wanted to investigate whether the CD44 advantage of monocyte-derived AM^occurred in a more physiological setting. Furthermore, it was of interest to determine to what extent self-renewal or monocyte recruitment contributes to the AM^population after inflammation. In order to study this, we first established a suitable acute lung inflammation mouse model using LPS. The course of LPS-induced inflammation was monitored over time by weight loss (Figure 3a) and the total number of leukocytes present in the BAL (Figure 3b ) that indicated the peak of inflammation occurred around day 3 and was resolved by day 14. Flow cytometry of the BAL cells, (Figure 3c-f) . Despite their initial loss, AM^quickly repopulated and expanded beyond preinflammatory values by day 7 (Figure 3d ). In addition, by day 7, CD11b þ Ly6C high monocytes were replaced with (Figure 3c ). Most of these became CD11c þ , gained Siglec F, and lost CD11b expression by day 14, suggesting further differentiation. Interestingly, as the monocytes differentiated, they also gained HA binding, another hallmark of AM^. By day 30, these cells were either absent or indistinguishable from resident AM^(CD11c þ , Siglec F þ , HA binding) (Figure 3c ,e). Overall, this raises the possibility that the transiently depleted AM^are capable of rapid self-renewal, whereas the recruited monocytes may undergo a slower differentiation process to eventually become AM^1 month after recruitment. Figure 4b ). By day 3, monocytes were losing Ly6C expression and by day 7 this had largely disappeared. Cells started to gain CD11c at day 7 and by day 14 were mostly CD11c þ and CD11b -, and many had gained the ability to bind HA and express Siglec F ( Figure 4b ). By day 30, the GFP þ cells were indistinguishable from the characteristic phenotype of AM^: CD11b À CD11c þ Siglec F þ and HA binding. These phenotypic changes in the green fluorescent protein (GFP) monocytes mirrored those of the host monocytes observed in Figure 3 . In addition, the number of GFP þ cells in the BAL peaked at day 3, as did host monocytes, then the number of GFP þ cells in the BAL decreased to a minimum at day 14, and then increased at day 30 ( Figure 4c ), suggesting that either the differentiated monocytes proliferated or entered the alveolar space from the lung tissue. The reduction in GFP þ cells in the lung between days 14 and 30 ( Figure 4c ) supports the latter possibility at day 30; however, detection of a small percentage of Ki67 þ GFP þ cells at day 45 also supports cell proliferation that occurred at a comparable rate to the host AM^( Figure 4d) . Furthermore, these GFP þ cells at day 45 were phenotypically indistinguishable from host AM^, by the expression levels of CD11c, Siglec F, CD11b, HA binding, SIRPa, CD206, and F4/ 80 (Figure 4e ).
CD44 exerts an advantage in monocyte-derived AM^after inflammation
Having identified that AM^can repopulate a few days after depletion by an inflammatory insult such as LPS, and that recruited monocytes can differentiate into a phenotypically identical AM^by day 30, we can now examine the effect of CD44 on AM^repopulation by self-renewal and from monocytes. To determine when CD44 influenced monocyte-derived AM^repopulation after inflammation, we repeated the above experiment using a 1:1 ratio of CD45.2 þ CD44 þ / þ and CD44 À / À monocytes purified from the BM of the respective mice injected IV into CD45.1 þ mice, 4 h after IT LPS injection (Figure 5a,b) (Figure 6a ), consistent with a majority of tissueresident peritoneal macrophages and a minority of small peritoneal macrophages, as described in ref. 23 These peritoneal macrophages (PM^) were CD11c À CD11b þ and non-HA binding (Figure 6b) , and phenotypically distinct from AM^. GFP þ PM^were instilled into the lungs of wild-type, nonirradiated mice, and isolated from the BAL 2 weeks later where they had gained similar levels of CD11c and HA binding as the resident AM^, but remained CD11b þ (Figure 6c ). This demonstrated that the alveolar environment induces HA binding. CSF-2 may induce CD44 to bind HA in the alveolar space, as CSF-2-but not CSF-1-derived BMDMs (BM-derived macrophages) bound HA. 16, 24 Furthermore, CSF-2-derived BMDMs have several phenotypic and functional similarities to AM^. 16 To investigate this, CSF-1-derived BMDMs were cultured with CSF-2 for 48 h and this partially upregulated their HA binding ability and CD11c expression (Figure 6d ). To test whether CSF-2 also induced PM^to bind HA, PM^were cultured with CSF-2 for 7 days in vitro. This did not induce HA binding in PM^, neither did the peroxisome proliferator-activated receptor-g (PPARg) agonist rosiglitazone (ROZ), 25 but together they significantly induced HA binding in the PM^ (Figure 6e ).
CD44 and HA binding promote AM^survival
To determine how CD44 was providing an advantage for AM^, we isolated CD44 À / À and CD44 þ / þ AM^from the BAL, and labeled these ex vivo AM^with Ki67 antibody, a marker of cell proliferation. The percentage of Ki67 þ AM^was not significantly different (Figure 7a ), suggesting no difference in cell cycling or proliferation rate at the steady state. However, when ex vivo AM^were labeled with 4',6-diamidino-2-phenylindole (DAPI) and Annexin V, CD44
À / À AMŝ howed significantly more apoptotic and dead cells than CD44 þ / þ AM^ (Figure 7b,c) .
AM^were also observed after equal numbers were cultured for 24 h (Figure 7c ). This showed that CD44 was providing a survival advantage for AM^, possibly by providing a survival signal to AM^. Given the distinct constitutive HA binding ability of CD44 on AM^, we investigated whether CD44 was binding to HA in the alveolar space. HA was detected by HA binding protein (HABP) that revealed intense staining around the bronchioles and identified CD11c þ Siglec F þ AM^as the major cells in the BAL that bound HA in vivo. In contrast, CD44
À / À AM^were poorly labeled by HABP, indicating significantly less surface HA (Figure 7d,e) . This suggested that CD44 þ / þ AM^, but not CD44 À / À AM^, were decorated with a HA coat. Further analysis by flow cytometry on ex vivo AM^from the BAL confirmed that CD44 þ / þ AM^were decorated with surface HA to a much greater extent than CD44 À / À AM^ (Figure 7f ), suggesting the cell surface HA was bound to CD44.
Incubation of CD44 þ / þ AM^with bovine hyaluronidase significantly reduced HABP labeling, indicating HABP binding was specific for surface HA (Figure 8a,b) . To determine the significance of this HA binding and its possible role in AMŝ urvival, ex vivo CD44 þ / þ and CD44 À / À AM^were incubated in phosphate-buffered saline (PBS), with or without bovine hyaluronidase or the HA blocking CD44 monoclonal antibody (mAb), KM81, for 1 h and then labeled with DAPI and Annexin V. Both HA removal and KM81 addition decreased the viability of CD44 þ / þ AM^to the levels observed with the CD44 À / À AM^, and these treatments had no effect on the CD44 À / À AM^ (Figure 8c,d) , indicating that the interaction of HA on AM^promoted their survival. To determine whether this interaction also had similar consequences in vivo, KM81 was instilled into the lung on days 0, 2, 4, and 6 to disrupt the interaction. On day 7, AMŵ ere isolated from the BAL, and the numbers of live, apoptotic, and dead cells were determined. KM81-treated mice had significantly more apoptotic and dead cells, and less live AMĉ ells than mice treated with an isotype-matched antibody (Figure 8e-g ), demonstrating that the interaction of CD44 with HA on AM^in the alveolar space is required for their optimal survival and the maintenance of normal AM^numbers at homeostasis. 
DISCUSSION
AM^develop from fetal monocytes and do not depend on adult monocytes for self-maintenance at homeostasis. 6, 7 Here, we show that the self-renewal of AM^contributes to the rapid AM^repopulation 7 days after LPS-induced inflammation and AM^depletion. We also show that, in contrast to steady-state AM^maintenance, adult monocytes contribute to the AMp opulation after inflammation, although to a lesser extent and over a slower time frame of B30 days. The relative contribution from AM^and monocytes may depend on the extent of lung damage and inflammation that, in turn, may affect the extent of AM^depletion. This initial depletion of AM^may alter the alveolar environment and expose a niche to allow monocyte engraftment and their subsequent differentiation into AM^. Although the transfer of GFP þ monocytes provided evidence for their differentiation into cells with an AM^phenotype (CD11c
þ , F4/80 low ) and similar proliferative capacity 45 days after lung inflammation, further transcriptomic and functional analysis is necessary before we can conclude that the monocytes have fully differentiated into bona fide AM^. Recent work shows monocyte-derived cells present in the lung 10 months after bleomycin-induced injury that express equal levels of Siglec F and have a very similar transcriptional signature to tissueresident AM^. 26 This report shows that the CD44 expressed on both fetal and BM-derived AM^is important for their survival. When CD44 þ / þ and CD44 À / À AM^were instilled into the lung, CD44 þ / þ AM^outcompeted CD44 À / À AM^under both noninflammatory and inflammatory conditions. In addition, BM-derived CD44 þ / þ AM^were more prevalent than CD44 À / À AM^after competitive BM reconstitution. This was a selective effect of CD44 on AM^, as donor-derived monocytes, neutrophils, and eosinophils all had equal proportions of CD44 þ / þ and CD44 À / À cells after BM reconstitution. Although all these cells express CD44, only AM^bind HA constitutively. Furthermore, when equal numbers of GFP þ
CD44
þ / þ and CD44 À / À BM-derived monocytes were adoptively transferred into the blood after LPS-induced lung inflammation, equal numbers of monocyte-derived cells were present at day 14. It was only by day 30, when they had gained the full HA binding AM^phenotype, that the CD44 þ / þ AMĥ ad an advantage. Together, this shows that CD44 exerts its competitive advantage on AM^, not monocytes, correlating with its ability to bind HA.
Previous studies have shown that instillation of PM^into the alveolar environment changes their transcriptional signature and phenotype toward that of an AM^, 8 although CD11b remains high. Another study also showed phenotypic changes when PM^were instilled into the alveolar space of Csf2rb À / À mice. 9 However, in both studies, very few cells repopulated the alveolar space, and after 8 weeks these cells did not rescue alveolar proteinosis in the Csf2rb À / À mice, whereas monocytes did. 9 Here, we found that HA binding, a key characteristic of AM^, was induced on PM^by the alveolar environment after 2 weeks, but CD11b remained high. As this PM^instillation contained a majority of tissue-resident PMâ nd a minority of F4/80 low macrophages, we cannot precisely determine the origin of these cells. However, HA binding was induced when these PM^were exposed to both CSF-2 and the PPARg agonist, ROZ, in vitro, suggesting that these two signals may be responsible for the induction of HA binding by macrophages in the alveolar space. CSF-2 induces the expression of the nuclear receptor PPARg, 5 and both are required for the differentiation of fetal monocytes into AMî n vivo. 4, 6 The induction of constitutive HA binding by the alveolar environment is a striking feature, as monocytes and PM^do not normally bind detectable levels of exogenously added HA, unless they are exposed to inflammatory stimuli. 24, 27, 28 However, AM^are not unique in their constitutive ability to engage HA, as splenic F4/80 þ macrophages can also bind HA, 29 and PM^are recruited to the site of liver injury in a CD44-and HA-dependent manner. 30 Together, these highlight the importance of environmental imprinting on HA binding and macrophage phenotype. Results from in vivo competition in wild-type mice show that CD44-deficient AM^have an intrinsic defect that may be because of their inability to bind HA. The presence of cell surface HA is a major difference between CD44 þ / þ and CD44 À / À AM^. CD44 þ / þ , but not CD44 À / À , AM^are decorated with HA in vivo. This was somewhat unexpected as others have shown that alveolar macrophages readily take up and degrade HA in vitro and in vivo during lung development. 17, 18 Nevertheless, surface-bound HA was functionally important as prevention of HA binding by a CD44 blocking antibody both ex vivo and in vivo or by enzymatic removal of HA on ex vivo cells reduced the survival of CD44 þ / þ AM^. Thus, we conclude the interaction of CD44 with HA provides a survival advantage for AM^. Supporting this, CD44 À / À mice had decreased numbers of AM^in the alveolar space, and CD44 À / À AM^were more susceptible to cell death. Together, this demonstrates the importance of the HA coat and its interaction with CD44 in AM^survival.
In the alveolar space, AM^reside between the surfactant and the alveolar epithelial cells (AECs). 3 Thus, one possible source of HA in the alveolar space is AECs. Type II AECs (AEC2) express hyaluronan synthase 2 and display HA on their surface 31 that may promote interactions with AM^. Other molecular interactions already exist between AECs and AM^t hat provide inhibitory signals to prevent AM^activation. 3 AM^binding to AECs may also facilitate AM^proximity to AEC-derived growth and survival factors such as CSF-2, to help sustain lung homeostasis. 32 Alternatively, HA may be scavenged from these cells and from the alveolar space, or AMt hemselves may synthesize HA that is then bound by surface CD44. Extracellular HA binding by CD44 on AM^could be integral to forming a HA-rich glycocalyx that may promote cell survival by protecting against environmental stress, for example, by protecting against reactive oxygen species, 33, 34 or against sheer stress. 35 Alternatively, HA binding to CD44 on AM^may provide prosurvival signals. High expression of CD44 has been linked with promoting effector T-cell survival and protection from Fas-mediated apoptosis in T helper type 1 cells 36 and antibody-induced CD44 ligation improves survival and resistance of cancer cells to drug-induced apoptosis. [37] [38] [39] However, it has been difficult to identify HA-mediated signaling events in cells.
40
AEC2 have stem cell-like properties in the adult lung and contribute to tissue repair. In a mouse model of bleomycininduced lung damage, AEC2 cells lacking HAS2 had lower levels of surface HA, showed increased apoptosis, and a reduced ability to proliferate and form colonies, implicating a role for surface HA in the survival and proliferation of AEC2. Furthermore, AEC2 from idiopathic pulmonary fibrosis patients also showed reduced surface HA and were less efficient in generating colonies compared with AEC2 from healthy individuals. 31 Similarly, CD44 and its interactions with HA have been implicated in promoting the self-renewal and survival of cancer-initiating cells. 41 Here, we add to this accumulating evidence for a role of HA binding by CD44 in promoting the survival of cells with stem cell-like renewal capacity by showing that HA-CD44 interactions support the survival of long-lived, self-renewing AM^. The specific effect of HA binding by CD44 on AM^survival highlights both CD44 and HA as possible targets for therapeutic intervention. Given the importance of AM^in maintaining lung immunosurveillance and homeostasis, strategies that improve the survival or self-renewal potential of these cells, especially in pathological conditions of lung inflammation, may result in therapeutic benefits. À / À mice 42 backcrossed with C57BL/6J mice for 9 generations, were housed and bred at the University of British Columbia (UBC, Vancouver, BC, Canada). Mating C57BL/6J and BoyJ mice gave C57BL/6JxBoyJ heterozygotes (CD45.1 þ , CD45.2 þ ). C57BL/6 mice expressing GFP from an a-actin-CMV hybrid promoter were provided by Dr Fabio Rossi (UBC) and cells from heterozygous GFP þ mice were used for the adoptive transfer experiments. All animal experiments were conducted with protocols approved by the University Animal Care Committee in accordance with the Canadian Council of Animal Care guidelines for ethical animal research.
Reagents. L-cell conditioned media containing CSF-1 were generated from L929 fibroblast cells and tissue culture supernatant from J558L cells was the source of CSF-2, as described previously. 16, 29 Fluoresceinconjugated HA was prepared using hyaluronic acid sodium salt from Rooster comb (Sigma-Aldrich, St. Louis, MO), as described previously. 43 High-molecular-weight HA (Lifecore Biomedical, Chaska, MN) was conjugated with Alexa Fluor-647 by AbLab (UBC) for HA-A647. Purified low endotoxin, HA-blocking, rat anti-mouse CD44 mAb, KM81, and rat IgG2a isotype-matched mAb were purchased from Cedarlane Laboratories (Burlington, ON, Canada). Recombinant mouse CSF-2 (carrier free) was purchased from BioLegend (San Diego, CA). Rosiglitazone (ROZ) was purchased from Cayman Chemical Company (Ann Harbor, MI). Cell isolation. Mice were killed by isoflurane overdose. BAL cells were harvested by catheterization of the trachea and washing thrice with 1 ml FC buffer. BAL cells were centrifuged and resuspended in red blood cell lysis buffer (0.84% NH 4 Cl in 10 mM Tris buffer, pH 7.2) for 5 min, and then centrifuged again and resuspended in FC buffer. The whole lung was then perfused with PBS via cardiac puncture of the right ventricle and harvested, minced, incubated in RPMI (with 0.7 mg ml À 1 Collagenase IV (Worthington, Lakewood, NJ), 50 mg ml À 1 of DNAse I (Worthington) for 1 h at 37 1C, and passed through a 70 mm cell strainer to generate the lung single-cell suspension that was treated with red blood cell lysis buffer, passed through a 35 mm cell strainer, and resuspended in FC buffer.
The peritoneal lavage, obtained with 5 ml of PBS, was centrifuged and treated with red blood cell lysis buffer for 5 min, then centrifuged and resuspended in FC buffer, incubated with 2.4G2 for 20 min, and labeled with biotinylated F4/80 antibody for 20 min. Then, PM^were isolated with anti-biotin MicroBeads and LS columns (Miltenyi Biotec) according to the manufacturer's instructions. Purity was 85% or above for the F4/80 high macrophages. Monocytes were isolated from the BM using the EasySep Mouse Monocyte Isolation Kit (Stemcell Technologies, Vancouver, BC, Canada) according to the manufacturer's instructions, and their purity was assessed by FC.
Induction of lung inflammation and adoptive monocyte transfer.
Mice were treated with 25 mg of Escherichia coli 0111:B4 LPS (SigmaAldrich) in 50 ml PBS via IT instillation. After 4 h, 0.5-1 Â 10 6 GFP þ BM monocytes resuspended in 200 ml PBS were injected IV into C57BL/6J host mice. Alternatively, 1-2 Â 10 6 CD45.
and CD44 À / À monocytes (1:1 ratio) were injected IV into the LPS-treated CD45.1 host. The lung and BAL were harvested at indicated times following LPS for FC analysis. The weight of LPS-treated mice were recorded daily for 7 days, and then on days 14 and 30.
À / À BM cells (1:1 ratio) were injected IV into lethally irradiated (24 h after gamma radiation 6.5 Gy, twice, 4 h apart) CD45.1 þ host mice. The perfused lung and BAL were harvested after 7 weeks for analysis. Generation of CSF-1 derived BMDMs. BM was isolated from murine femurs and tibia, and CSF-1-derived BMDMs were generated as previously described. 29 Macrophage stimulation with CSF-2 and ROZ. CSF-1 BMDMs (2 Â 10 5 ) were collected on day 5 and cultured in 200 ml Dulbecco's modified Eagle's medium DMEM (Invitrogen, Carlsbad, CA) with 10% fetal calf serum in nontissue culture-treated 96-well plates in the presence or absence of 4% CSF-2 containing supernatant for 48 h. Cells were then analyzed by FC. Purified F4/80 þ PM^(2 Â 10 5 ) were cultured in 200 ml complete RPMI-1640 media (with 10% fetal calf serum, 20 mM HEPES, 1 Â nonessential amino acid, 55 mM 2-mercaptoethanol, 1 mM sodium pyruvate, 2 mM L-glutamine, 50 U ml À 1 penicillin/streptomycin, all from Invitrogen) in nontissue culturetreated 96-well plates in the presence or absence of 20 ng ml À 1 of mouse recombinant CSF-2, 1 mM ROZ, or 20 ng ml À 1 of CSF-2 and 1 mM ROZ for 7 days, with a media change at days 3 and 6. Cells were analyzed by FC on day 7.
Measuring AM^cell death and surface HA labeling. AM^were labeled with DAPI and fluorescent Annexin V in 10 mM HEPES (pH 7.4), 140 mM NaCl, and 2.5 mM CaCl 2 for 20 min for FC analysis. Alternatively, 1 Â 10 5 cells were plated in 96-well nontissue culturetreated plates in complete RPMI-1640 media and incubated at 37 1C. After 24 h, the cells were collected with Versene and analyzed for Annexin V and DAPI. Cell surface HA for FC was determined by biotinylated HABP (Millipore Sigma, St. Louis, MO) and streptavidin-PE-Cy7 (Affymetrix eBioscience) labeling. AM^were incubated in 100 ml PBS containing 20 U of bovine hyaluronidase (Sigma-Aldrich) or 100 ml of KM81 hybridoma (ATCC, Manassas, VA, TIB-241) tissue culture supernatant containing the CD44 blocking antibody KM81 for 1 h at 37 1C to remove surface HA or block CD44-HA interactions, respectively.
Confocal microscopy. Lungs were harvested from isofluraneanesthetized mice and fixed by immersing into ice-cold 4% paraformaldehyde for 2 h. Fixed tissue was embedded in NEG-50 freezing matrix (ThermoFisher) and snap frozen in dry ice cooled isopentane. Then, 12 mm cryosections were cut and thaw mounted onto Superfrost Plus microscope slides (ThermoFisher). Tissue sections were fixed again with acetone, blocked with 10% goat serum, and labeled with CD11c and Siglec F antibodies followed by goat-anti hamster Alexa 647 and goat anti-rat Alexa 488 (ThermoFisher) respectively and biotinylated HABP followed by streptavidin Alexa 568 (ThermoFisher). Images were acquired using the 20 Â dry objective of a FV1000 laser scanning confocal microscope (Olympus, Richmond Hill, ON, Canada) equipped with 405, 488, 543, and 633 nm laser lines.
Data analysis. FC was analyzed using FlowJo VX (Treestar, Ashland, OR). Flow cytometry plots shown were first gated by size, singlets, and live/dead stain. Graphs were generated using GraphPad Prism 6 (La Jolla, CA). Data shown are the average±s.d. Significance was determined by Student's two-tailed, unpaired or paired t-test with *Po0.05, **Po0.01, and ***Po0.001. Confocal microscopy was analyzed using the Fiji distribution package of ImageJ 1.51 (NIH, Rockville, MD). The mean pixel intensity of HABP for CD11c þ Siglec F þ CD44 þ / þ or CD44 À / À AM^was determined, data shown are individual cell measurements and the average ± s.d., and statistical significance was tested by nonparametric unpaired Mann-Whitney test with ***Po0.001.
